logo

Jounce Therapeutics, Inc. (JNCE)



Trade JNCE now with
  Date
  Headline
4/3/2019 8:11:52 AM Jounce Therapeutics Presents Preclinical Data From JTX-8064 Program At 2019 AACR Annual Meeting
3/6/2019 6:40:07 AM Jounce Therapeutics Q4 Net Loss $2.0 Mln Or $0.06/Shr Vs $9.4 Mln Or $0.29/Shr Last Year
1/3/2019 8:08:46 AM Jounce Therapeutics Completes Enrollment In First Cohort For Its Phase 1 Dose Escalation Clinical Trial Of JTX-4014
11/13/2018 6:46:41 AM Jounce Therapeutics Q3 Net Loss $7.6 Mln Or $0.23/Shr Vs Loss $4.1 Mln Or $0.13/Shr Last Year
8/9/2018 6:36:31 AM Jounce Therapeutics Q2 Net Loss $4.7 Mln Or $0.14/Shr Vs Loss $3.4 Mln Or $0.11/Shr Last Year
5/9/2018 6:38:16 AM Jounce Therapeutics Q1 Net Loss $13.0 Mln Or $0.40/Shr Vs Loss $0.4 Mln Or $0.02/Shr Last Year
4/12/2018 8:15:10 AM Jounce Therapeutics To Present Nonclinical Translational Data At 2018 AACR Annual Meeting
3/8/2018 6:35:04 AM Jounce Therapeutics Q4 Loss Per Share $0.29 Vs Profit $0.05 Last Year